Alpha Teknova, Inc.
- TKNO
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Life Sciences Reagents
- Biopharma Supply (Cell Culture)
$6.80
Today −3.95%Quote Oct 19, 2026, 08:00 PM UTC
−12.71%over the last month
Max drawdown −27.1%From 1-month high −27.1%3 months +27.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Alpha Teknova
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions.
Where the money comes from
Q2 2026 revenue $12.2M
- Lab Essentials$9.2M75.4%
- Clinical Solutions$2.4M19.9%
- Other Product$573,0004.7%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
158
Founded
1996
Market value
$365.1M
Quote Oct 19
Floor
$6.44
5.3% below price
Resistance
$7.45
9.5% above price
Price vs analyst targets
4 analysts
Lowest target
$7.00Highest target
$9.00
$7.00Highest target
$9.00
- Price $6.80
- Average target $8.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 18% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TKNOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free